September 11, 2020 Comments Off on Patent delisted for Boehringer Ingelheim drug JENTADUETO Posted in: Uncategorized
Annual Drug Patent Expirations for JENTADUETO Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are twelve patents…
The post Patent delisted for Boehringer Ingelheim drug JENTADU…
September 11, 2020 Comments Off on Patent delisted for Boehringer Ingelheim drug GLYXAMBI Posted in: Uncategorized
Annual Drug Patent Expirations for GLYXAMBI Glyxambi is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from two suppliers. There are eleven patents…
The post Patent delisted for Boehringer Ingelheim drug GLYXAMBI ap…
